BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 4:06:00 PM | Browse: 1355 | Download: 1909
Publication Name World Journal of Gastrointestinal Surgery
Manuscript ID 9613
Country Brazil
ISSN 1948-9366 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Surgery
Manuscript Type Case Report
Article Title Downstaging and resection after neoadjuvant therapy for fibrolamellar hepatocellular carcinoma
Manuscript Source Unsolicited Manuscript
All Author List Gilton Marques Fonseca, Antonio Drauzio Varella, Fabricio Ferreira Coelho, Emerson Shigueaki Abe, Rodrigo Blanco Dumarco and Paulo Herman
Funding Agency and Grant Number
Corresponding Author Gilton Marques Fonseca, MD, Digestive Surgery Division, Department of Gastroenterology, University of S?o Paulo School of Medicine, Avenida Doutor Enéas de Carvalho Aguiar, 255, Instituto Central, 9° Andar, Sala 9074, 05403-900, S?o Paulo, Brazil. medgilton@yahoo.com.br
Key Words Chemotherapy; Gemcitabine; Oxaliplatin; Hepatectomy; Hepatic veins; Fibrolamellar hepatocellular carcinoma
Core Tip Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare malignant liver neoplasm. The best treatment option is a surgical resection with liver hilum lymph node dissection. Currently there is no established systemic drug treatment for patients with locally advanced or metastatic disease. In this report, a patient with advanced FLHCC, initially considered unresectable due to vascular invasion, exhibited a significant tumor reduction following systemic chemotherapy with gemcitabine-oxaliplatin, allowing resection. This was an unusual case where gemcitabine-oxaliplatin treatment led to a significant tumor downstaging enabling curative resection. Additional studies are needed to confirm the efficacy of the systemic drug treatment for FLHCC.
Publish Date 2014-07-20 20:11
Citation Fonseca GM, Varella AD, Coelho FF, Abe ES, Dumarco RB, Herman P. Downstaging and resection after neoadjuvant therapy for fibrolamellar hepatocellular carcinoma. World J Gastrointest Surg 2014; 6(6): 107-111
URL http://www.wjgnet.com/1948-9366/full/v6/i6/107.htm
DOI http://dx.doi.org/10.4240/wjgs.v6.i6.107
Full Article (PDF) WJGS-6-107.pdf
Full Article (Word) WJGS-6-107.doc